The Hygiology Post ® is presenting information about a company that seems to have much potential to help many people. The years 2012, 2013, and 2014 do appear to likely be pivotal years in determining how helpful the patented technologies may actually be for people. Senesco Technologies has continued to update information on its web site. As a matter of disclosure : The author continues to be a current shareholder in the company.
An article posted on the Senesco Technologies web site last month (https://www.senesco.com/newsitem.php?id=298; obtained on 4-22-14) began the following way:
Senesco Opens Two New Clinical Trial Sites and Initiates Treatment of the First Patient in South Africa
BRIDGEWATER, N.J. (March 12th, 2014) – Senesco Technologies, Inc. (‘Senesco’ or the ‘Company’) (OTC QB: SNTI) reported the opening of two new sites in the Republic of South Africa at Pretoria East Hospital and Groote Schuur Hospital in Cape Town. Treatment of the first patient in South Africa has been initiated in Senesco’s Phase 1b/2a clinical study of its product candidate, SNS01-T.
‘We are excited to have opened our first clinical sites outside of North America,’ stated Leslie J. Browne, Ph.D., President and Chief Executive Officer of Senesco. ‘The urban locations of Cape Town and Pretoria will provide access to a broader population of myeloma and lymphoma patients.’
Pretoria East Hospital, a modern 358-bed facility, includes the Albert Stem Cell Transplant Unit which is the largest center of its kind in Africa. This hematology program mostly treats patients with blood and marrow disorders, lymph cancers and also metabolic disorders. It has state-of-the-art equipment and facilities to rival those found anywhere else in the world.
Groote Schuur Hospital (GSH) is the teaching hospital of the University of Cape Town (UCT) which first gained global fame when, in December 1967, a young UCT educated surgeon named Dr. Christiaan Barnard completed the world’s first successful human heart transplant. GSH has a Clinical Hematology Division that provides comprehensive services to patients with blood disorders, including hematological malignancies. There is an active bone marrow transplant program, which is a national referral center.”
The Hygiology Post ® welcomes feedback from readers as to whether the articles (individually and/or collectively) help fulfill its vision and mission.
Louis DeCola, Jr. © 2014 The Hygiology Post ®